Jane Street
KRYS icon

Jane Street’s Krystal Biotech KRYS Stock Holding History

Jane Street’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
3,200
-4,100
-56% -$1.23M ﹤0.01% 6167
2026
Q1 		$1.89M Sell
7,300
-16,500
-69% -$4.39M ﹤0.01% 5212
2025
Q4 		$5.87M Sell
23,800
-32,000
-57% -$6.74M ﹤0.01% 2992
2025
Q3 		$9.85M Buy
55,800
+2,000
+4% +$299K ﹤0.01% 2444
2025
Q2 		$7.4M Buy
53,800
+48,800
+976% +$7.17M ﹤0.01% 2516
2025
Q1 		$902K Buy
5,000
+1,800
+56% +$303K ﹤0.01% 5759
2024
Q4 		$501K Sell
3,200
-51,500
-94% -$9.14M ﹤0.01% 6781
2024
Q3 		$9.96M Buy
54,700
+600
+1% +$116K ﹤0.01% 1915
2024
Q2 		$9.93M Sell
54,100
-4,300
-7% -$722K ﹤0.01% 2056
2024
Q1 		$10.4M Buy
58,400
+3,500
+6% +$486K ﹤0.01% 1769
2023
Q4 		$6.81M Sell
54,900
-7,800
-12% -$865K ﹤0.01% 2427
2023
Q3 		$7.27M Buy
62,700
+36,600
+140% +$4.47M ﹤0.01% 2140
2023
Q2 		$3.06M Buy
+26,100
New +$2.66M ﹤0.01% 3458
2022
Q3 		– Sell
-4,200
Closed -$276K – 10100
2022
Q2 		$276K Sell
4,200
-1,100
-21% -$68.4K ﹤0.01% 7746
2022
Q1 		$353K Sell
5,300
-54,300
-91% -$3.39M ﹤0.01% 8120
2021
Q4 		$4.17M Buy
+59,600
New +$3.47M ﹤0.01% 3134

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jane Street's KRYS Position: Q2 2026 in Review

Jane Street opened a new position in Krystal Biotech (KRYS) in Q2 2026: 956 shares worth $355K. The stake represents ﹤0.01% of the portfolio and ranks #8828 among its holdings. This is a return to the name: Jane Street previously reported a position in KRYS as recently as Q3 2025.

Jane Street first reported a position in KRYS in Q3 2019 and has held it in 16 quarters since. The position peaked at $16.7M in Q1 2024. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Jane Street held 956 shares of Krystal Biotech worth $355K as of Q2 2026.
  • Krystal Biotech was a new Jane Street position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8828 holding.
  • Jane Street first reported a position in Krystal Biotech in Q3 2019 and has held it in 16 quarters since.
  • Jane Street's Krystal Biotech position peaked at $16.7M in Q1 2024.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.